CiVi Biopharma Inc. is a US-based, privately-held biopharmaceutical company, founded in 2016. The Company's research and development activities are focused on creating novel therapies for cardiovascular, metabolic and related diseases. CiVi’s innovative pipeline includes CiVi007, a long-acting PCSK9 third-generation Locked Nucleic Acid antisense molecule being developed for the treatment of hypercholesterolemia and the prevention of cardiovascular disease. In addition, the Company currently has other clinical stage development program activity aimed at treating severe liver diseases.
View Top Employees from CiVi Biopharma, Inc.| Website | http://www.civibio.com |
| Revenue | $2 million |
| Employees | 12 (11 on RocketReach) |
| Founded | 2016 |
| Address | 5425 Wisconsin Ave 6th Floor, Chevy Chase, Maryland 20815, US |
| Phone | (301) 968-2390 |
| Technologies |
JavaScript,
HTML,
PHP
+9 more
(view full list)
|
| Industry | Clinical Trials, Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Health Care, Cardiovascular Diseases, Pharmaceutical, Metabolic Diseases |
| SIC | SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular CiVi Biopharma, Inc. employee's phone or email?
CiVi Biopharma, Inc. Questions
The CiVi Biopharma, Inc. annual revenue was $2 million in 2024.
Allison Widlitz is the Vice President Medical Affairs of CiVi Biopharma, Inc..
11 people are employed at CiVi Biopharma, Inc..
CiVi Biopharma, Inc. is based in Chevy Chase, Maryland.
The NAICS codes for CiVi Biopharma, Inc. are [3254, 325, 32].
The SIC codes for CiVi Biopharma, Inc. are [28, 80, 283].
Top CiVi Biopharma, Inc. Employees
-
21
-
55
-
23
-
25
-
ViewCaryl Weinbaum
Human Resources and Executive Support at CiVi Biopharma, Inc.
Washington, DC, US45 -
ViewChrista-Lynn Vampola
Executive Director, Clinical Development at CiVi Biopharma, Inc.
Los Altos, California, United States22 -
11
